Jan 13, 2023, 09:07 AM by User Not Found

Bio-IT World | In his second J.P. Morgan Healthcare Conference address on behalf of Pacific Biosystems, CEO Christian Henry gave a summary of 2022 numbers and updates on the new sequencing platforms the company announced in October: the Revio long-read platform and the Onso short-read platform.

Jan 13, 2023, 01:00 AM by User Not Found

Bio-IT World | In BioPharma, development to manufacturing often feel as if they are separated by an invisible wall. While the enterprise may be joint, development and manufacturing cultures are distinct. Poor information sharing can make findings feel like closely guarded secrets. This siloed approach was the accepted norm in earlier eras. Now, it is due for a major renovation.

Jan 12, 2023, 09:53 AM by

Jan 12, 2023, 09:12 AM by User Not Found

Bio-IT World | Illumina President and CEO Francis deSouza kicked off his annual J.P. Morgan Healthcare Conference presentation highlighting the breadth of the genomics market. deSouza sees a $120 billion total addressable market for Illumina, with oncology testing representing more than half of the opportunity.

Jan 11, 2023, 10:58 AM by

Jan 11, 2023, 10:57 AM by

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Jan 11, 2023, 01:00 AM by User Not Found

Bio-IT World | Serge Saxonov, CEO and co-founder of 10x Genomics, kicked off Monday’s sessions at the 41st annual J.P. Morgan Healthcare Conference with an overview of the company’s overall progress in its Visium, Chromium, and Xenium platforms. Instead of delving too deeply in specific product announcements, Saxonov emphasized the strength of the 10x team, the mergers and acquisitions that have led to the development of the platforms, and the breadth of the company offerings.

Jan 10, 2023, 11:31 AM by

CSafe Connect enables a truly connected supply chain by bringing together product ordering, shipment analytics and customer support under a single login

Jan 10, 2023, 11:31 AM by

Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.

Jan 10, 2023, 11:30 AM by

Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.

Jan 10, 2023, 11:28 AM by

Jan 10, 2023, 11:27 AM by

Jan 10, 2023, 01:00 AM by User Not Found

Bio-IT World | Multiyear efforts using genetic engineering to study cancer development and interactions with components of the anti-tumor immune response were the subject of the Ernst W. Bertner Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center. The focus was on genetically engineered mouse models established to understand how cancer develops over time and to inform new approaches for both earlier detection and better treatment.

Jan 9, 2023, 10:20 AM by

OncoDxRx's PGA technology is the world-first test that enables gene-drug matching for optimal treatment regimen from hundreds of anti-cancer drugs based on patients’ own gene expression profiles

Jan 9, 2023, 09:57 AM by

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Jan 6, 2023, 09:14 AM by

Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team

Jan 6, 2023, 09:12 AM by

Molecular Devices, a leader in high-performance life sciences solutions, on Wednesday announced a new collaboration with Advanced Solutions, a biofabrication and life sciences robotics company. This new collaboration takes the form of a turnkey solution that systematically bioprints organoids in a fully-automated enclosure, with award-winning high-content imaging capabilities that inform the modeling and screening process for increased precision--enabling the industry to grow, screen, and analyze high-quality, viable, 3D cell cultures at scale.

Jan 5, 2023, 10:22 AM by

CD BioSciences recently launched another comprehensive panel of research solutions for autophagic cell death studies.

Jan 5, 2023, 10:22 AM by

Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.

Jan 5, 2023, 10:21 AM by

STEMart has recently introduced API Impurity Identification services for global clients.